Navigation Links
Phigenics Research Challenges Accuracy Of Conventional Legionella Testing Protocol
Date:4/19/2012

NAPERVILLE, Ill., April 19, 2012 /PRNewswire/ -- Phigenics LLC, an innovative water management services company, announced today the publication of a research paper that demonstrates up to 33% false-positive test results for Legionella bacteria when following conventional sampling methods. A false-positive result means the test indicated Legionella was present in the water system at detectable levels when in fact it was below detectable levels at the time the sample was taken from the building water system. The greatest degree of error was found in utility water systems where 33% of 580 samples shipped from hundreds of building water systems showed false-positive results. There were also a significant number of false-negative results observed from many thousands of shipped water samples transported from hundreds of building water systems. "Inaccuracy in Legionella Tests of Building Water Systems Due to Sample Holding Time," was recently published by Phigenics in Water Research, the official journal of the International Water Association (IWA).

"The impact of the research is significant in that it provides robust statistical proof that results from conventional Legionella testing can be inaccurate and misleading," says Dr. William McCoy, Chief Technology Officer of Phigenics and Chair of ASHRAE Standards Project Committee 188, Prevention of Legionellosis Associated with Building Water Systems. "These inaccuracies can be eliminated by culturing the bacteria that causes Legionnaires' disease immediately after taking a water sample on-site at the facility location. This simple change in procedure eliminates the potential of bacterial amplification or decline in water samples during transport to the laboratory. Shipping water samples to the laboratory has been shown to cause inaccurate or misleading results from many building water systems."

"We are predicting significant increases in Legionella testing over the coming years in commercial and institutional markets due to new Legionella Hazard Analysis and Critical Control Point (HACCP) standards such as ASHRAE Standard 188P and others that are scheduled for official publishing over the next twelve months or so," says Ashton McCombs, President of Phigenics. "This research is very important because the last thing anyone wants is to be making Legionella treatment and control decisions based on inaccurate testing results."

"It is possible to culture bacteria immediately upon taking a water sample on-site at the facility location, and thereby completely eliminate testing inaccuracies caused by water sample transit time," says Dr. McCoy. "The problem historically has been that it was not commercially practical to implement on-site cultures at any scale. This is an important problem that Phigenics has solved by offering a field practical method to immediately start the culture on-site. Instead of shipping a water sample, the user ships the cultured bacteria. Starting the culture immediately also significantly reduces the time required before test results can be reported to the user. "

For a full copy of "Inaccuracy in Legionella Tests of Building Water Systems Due to Sample Holding Time," published in Water Research, or to obtain more information on Legionnaires' disease, go to http://www.phigenics.com/news/archive/.

About Phigenics

Phigenics provides an innovative new class of water management services engineered for facility owners and managers to ensure that all water found in hospitals, hotels, resorts, casinos, universities, commercial buildings, cruise lines and government facilities is safe and efficient. This includes all drinking water, decorative fountains, spas, swimming pools, misters, showers, humidifiers, air washers, cooling towers, heating systems, waste water and more. Core services include expert consulting, smart water management systems, and patented analytical laboratory services. Phigenics provides a refreshing break from traditional water treatment models by not selling chemicals or water treatment equipment, thereby enabling expert services and systems that are compatible with any water treatment technology.

Phigenics CTO Dr. William McCoy serves as Chair of the ASHRAE Standards Project Committee 188, Prevention of Legionellosis Associated with Building Water Systems. The Phigenics Analytical Services Laboratories (PASL) are certified as proficient in the Environmental Legionella Isolation Techniques Evaluation (ELITE) program administered by the Centers for Disease Control and Prevention (CDC). PASL has passed every proficiency test since the beginning of the program with a score of 100% correct.

www.phigenics.com


'/>"/>
SOURCE Phigenics LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Carbon capture and storage -- new research from UKERC shows tough road ahead to realize potential
2. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
3. Quality Standards Established for Competition to Identify Best Researchers in the US
4. Riordan Clinic Research Institute Has Developed and Patented a Process for the Assessment of the Energy Metabolism in Patients with Chronic Fatigue Syndrome
5. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
6. GenVec Announces Research on Improved Vaccine Vectors
7. Researchers reveal why some pain drugs become less effective over time
8. inVentiv Health Completes Acquisition of Kforce Clinical Research
9. Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer
10. Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012
11. Researchers Identify New Regulator in Allergic Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... the business of innovation is taking over sports. On Thursday, December 15th a ... how technology is disrupting the playing field at a Smart Talk session. Smart ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire-USNewswire/ ... treatments for congestive heart failure and type 2 ... license for a novel adeno-associated virus (AAV) vector ... Kay , M.D., Ph.D., at Stanford University. The ... of its paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... that provide essential device-to-computer interconnect using USB or PCI Express, announced the FOMD-ACV-A4, ... The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a standard 204-pin ...
(Date:12/8/2016)...  Anaconda BioMed S.L., a pre-clinical stage medical device ... neuro-thrombectomy system for the treatment of Acute Ischemic Stroke ... to join its Scientific Advisory Board (SAB). The SAB ... scientific and clinical experts to Anaconda BioMed S.L., as ... ® to its clinical phase. The SAB is ...
Breaking Biology Technology:
(Date:11/28/2016)... LONDON , Nov. 28, 2016 ... at a rate of 16.79%" The biometric system ... to grow further in the near future. The biometric ... 32.73 billion in 2022, at a CAGR of 16.79% ... biometrics system, integration of biometric technology in smartphones, rising ...
(Date:11/22/2016)... According to the new market research report "Biometric System Market by Authentication ... (Hardware and Software), Function (Contact and Non-contact), Application, and Region - Global ... from USD 10.74 Billion in 2015 to reach USD 32.73 Billion by ... Continue Reading ... ...
(Date:11/21/2016)... 21, 2016   Neurotechnology , a provider ... today announced that the MegaMatcher On Card fingerprint ... for the NIST Minutiae Interoperability Exchange (MINEX) ... mandatory steps of the evaluation protocol. ... test of fingerprint templates used to establish compliance ...
Breaking Biology News(10 mins):